Presentation at ESC Acute Cardiovascular Care 2018

MCG clinical study was presented at ESC Acute Cardiovascular Care 2018 in March 3rd, in Milan, Italy.

This study was conducted in Myanmar, where the locations of the cath-lab are very limited.  MCG was compared with CAG, and it showed high sensitivity and specificity for the presence of severe CAD by CAG (≥ 75%).

By Author, it is evaluated as “MCG could be used for prompt detection of severe CAD in order to start appropriate (PCI/Optimal Medical Therapy) treatments in the emerging country such as Myanmar where less medical facilities and skills are available.”

カテゴリー: News パーマリンク